Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

pfizer ab - oxaliplatin - koncentrat till infusionsvätska, lösning - 5 mg/ml - oxaliplatin 5 mg aktiv substans - oxaliplatin

Europese Unie - Zweeds - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - prekursorcell lymfoblastisk leukemi-lymfom - antineoplastiska medel - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 5 mg - oxikodonhydroklorid 5 mg aktiv substans; laktosmonohydrat hjälpämne

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 20 mg - oxikodonhydroklorid 20 mg aktiv substans; laktosmonohydrat hjälpämne

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 40 mg - laktosmonohydrat hjälpämne; oxikodonhydroklorid 40 mg aktiv substans

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 15 mg - oxikodonhydroklorid 15 mg aktiv substans; laktosmonohydrat hjälpämne

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 10 mg - oxikodonhydroklorid 10 mg aktiv substans; laktosmonohydrat hjälpämne

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 30 mg - oxikodonhydroklorid 30 mg aktiv substans; laktosmonohydrat hjälpämne

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 60 mg - laktosmonohydrat hjälpämne; oxikodonhydroklorid 60 mg aktiv substans

Zweden - Zweeds - Läkemedelsverket (Medical Products Agency)

teva sweden ab - oxikodonhydroklorid - depottablett - 80 mg - laktosmonohydrat hjälpämne; oxikodonhydroklorid 80 mg aktiv substans